Combined effects of hematoporphyrin derivative phototherapy and adriamycin in a murine tumor model

E. S. Edell, Denis Cortese

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Hematoporphyrin derivative phototherapy (HpD-PT) is currently being used experimentally in the treatment of various malignancies. The effectiveness of HpD-PT appears to be limited to superficial malignancies because of its inability to penetrate more than 0.5 - 1 cm. The mechanism of action has been demonstrated to result from the formation of toxic singlet oxygen and other oxygen radicals. Preliminary work suggested that the addition of other chemical agents known to produce toxic oxygen radicals may enhance the effects of HpD-PT. To test this hypothesis, we examined the effectiveness of HpD-PT in the Walker 256 carcinosarcoma with and without adriamycin. Tumor kill was estimated by calculating the area of necrosis on photomicrographic sections. From this area, a radius of tumor necrosis was determined and compared among various control and experimental groups. HpD-PT was effective in this model compared to control groups (radius of necrosis 3.79 ± 0.97 mm vs. 2.60 ± 1.26 mm, P< .05). The addition of Adriamycin significantly increased the radius of necrosis when compared to HpD-PT (4.57 ± 1.70 mm vs. 3.69 ± 0.97 mm, P < .01). From this work we conclude that HpD-PT demonstrates effective tumor killing in this murine model. The addition of Adriamycin significantly increased tumor kill.

Original languageEnglish (US)
Pages (from-to)413-417
Number of pages5
JournalLasers in Surgery and Medicine
Volume8
Issue number4
StatePublished - 1988
Externally publishedYes

Fingerprint

Hematoporphyrin Derivative
Phototherapy
Doxorubicin
Necrosis
Neoplasms
Poisons
Reactive Oxygen Species
Walker Carcinoma 256
Singlet Oxygen
Control Groups

ASJC Scopus subject areas

  • Surgery

Cite this

Combined effects of hematoporphyrin derivative phototherapy and adriamycin in a murine tumor model. / Edell, E. S.; Cortese, Denis.

In: Lasers in Surgery and Medicine, Vol. 8, No. 4, 1988, p. 413-417.

Research output: Contribution to journalArticle

@article{b99d216c1daf4284a8411179932ee059,
title = "Combined effects of hematoporphyrin derivative phototherapy and adriamycin in a murine tumor model",
abstract = "Hematoporphyrin derivative phototherapy (HpD-PT) is currently being used experimentally in the treatment of various malignancies. The effectiveness of HpD-PT appears to be limited to superficial malignancies because of its inability to penetrate more than 0.5 - 1 cm. The mechanism of action has been demonstrated to result from the formation of toxic singlet oxygen and other oxygen radicals. Preliminary work suggested that the addition of other chemical agents known to produce toxic oxygen radicals may enhance the effects of HpD-PT. To test this hypothesis, we examined the effectiveness of HpD-PT in the Walker 256 carcinosarcoma with and without adriamycin. Tumor kill was estimated by calculating the area of necrosis on photomicrographic sections. From this area, a radius of tumor necrosis was determined and compared among various control and experimental groups. HpD-PT was effective in this model compared to control groups (radius of necrosis 3.79 ± 0.97 mm vs. 2.60 ± 1.26 mm, P< .05). The addition of Adriamycin significantly increased the radius of necrosis when compared to HpD-PT (4.57 ± 1.70 mm vs. 3.69 ± 0.97 mm, P < .01). From this work we conclude that HpD-PT demonstrates effective tumor killing in this murine model. The addition of Adriamycin significantly increased tumor kill.",
author = "Edell, {E. S.} and Denis Cortese",
year = "1988",
language = "English (US)",
volume = "8",
pages = "413--417",
journal = "Lasers in Surgery and Medicine",
issn = "0196-8092",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Combined effects of hematoporphyrin derivative phototherapy and adriamycin in a murine tumor model

AU - Edell, E. S.

AU - Cortese, Denis

PY - 1988

Y1 - 1988

N2 - Hematoporphyrin derivative phototherapy (HpD-PT) is currently being used experimentally in the treatment of various malignancies. The effectiveness of HpD-PT appears to be limited to superficial malignancies because of its inability to penetrate more than 0.5 - 1 cm. The mechanism of action has been demonstrated to result from the formation of toxic singlet oxygen and other oxygen radicals. Preliminary work suggested that the addition of other chemical agents known to produce toxic oxygen radicals may enhance the effects of HpD-PT. To test this hypothesis, we examined the effectiveness of HpD-PT in the Walker 256 carcinosarcoma with and without adriamycin. Tumor kill was estimated by calculating the area of necrosis on photomicrographic sections. From this area, a radius of tumor necrosis was determined and compared among various control and experimental groups. HpD-PT was effective in this model compared to control groups (radius of necrosis 3.79 ± 0.97 mm vs. 2.60 ± 1.26 mm, P< .05). The addition of Adriamycin significantly increased the radius of necrosis when compared to HpD-PT (4.57 ± 1.70 mm vs. 3.69 ± 0.97 mm, P < .01). From this work we conclude that HpD-PT demonstrates effective tumor killing in this murine model. The addition of Adriamycin significantly increased tumor kill.

AB - Hematoporphyrin derivative phototherapy (HpD-PT) is currently being used experimentally in the treatment of various malignancies. The effectiveness of HpD-PT appears to be limited to superficial malignancies because of its inability to penetrate more than 0.5 - 1 cm. The mechanism of action has been demonstrated to result from the formation of toxic singlet oxygen and other oxygen radicals. Preliminary work suggested that the addition of other chemical agents known to produce toxic oxygen radicals may enhance the effects of HpD-PT. To test this hypothesis, we examined the effectiveness of HpD-PT in the Walker 256 carcinosarcoma with and without adriamycin. Tumor kill was estimated by calculating the area of necrosis on photomicrographic sections. From this area, a radius of tumor necrosis was determined and compared among various control and experimental groups. HpD-PT was effective in this model compared to control groups (radius of necrosis 3.79 ± 0.97 mm vs. 2.60 ± 1.26 mm, P< .05). The addition of Adriamycin significantly increased the radius of necrosis when compared to HpD-PT (4.57 ± 1.70 mm vs. 3.69 ± 0.97 mm, P < .01). From this work we conclude that HpD-PT demonstrates effective tumor killing in this murine model. The addition of Adriamycin significantly increased tumor kill.

UR - http://www.scopus.com/inward/record.url?scp=0023708081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023708081&partnerID=8YFLogxK

M3 - Article

C2 - 2971847

AN - SCOPUS:0023708081

VL - 8

SP - 413

EP - 417

JO - Lasers in Surgery and Medicine

JF - Lasers in Surgery and Medicine

SN - 0196-8092

IS - 4

ER -